Industry News
An animated adventure for the masses
'Mass Hysteria' is the third instalment in an animated online series featuring the SI Superheroes. [ + ]
Hard to get up in the morning — blame your genes
The personal genetics company 23andMe has released the results of one of the largest genome-wide association studies of its kind, identifying genetic variants associated with being a morning person. [ + ]
The new home of industrialised proteomics
The ACRF International Centre for the Proteome of Cancer (ProCan) will serve as the flagship for 'industrialised proteomics' — that is, large-scale protein analysis. [ + ]
TBG Diagnostics relisted on ASX
TBG Diagnostics, formerly known as Progen Pharmaceuticals, has been relisted on the ASX under the code TDL. [ + ]
Alan Finkel commences as Chief Scientist
In his first statement as Australia's Chief Scientist, Dr Alan Finkel AO said he wants to use his new position to "tell Australia's great success stories". [ + ]
Determining the risk of prostate cancer death
Researchers have identified a prognostic biomarker, the neuropeptide pro-NPY, which may help determine the risk of dying from prostate cancer. [ + ]
Geoscientists win travel grants
The Australian Geoscience Council and the Australian Academy of Science have announced the winners of the 34th International Geological Congress Travel Grants, worth $30,000. [ + ]
Wrinkle-free fabric that's environmentally friendly
Researchers have reported a method for making wrinkle-resistant cotton fabrics that is said to be more environmentally friendly and cost-effective than current techniques. [ + ]
US patent granted for IMP731 antibody
The United States Patent and Trademark Office has granted a patent for the IMP731 antibody, owned by Australian biotech company Prima BioMed. [ + ]
Healthcare executive John Chiplin joins Sienna Cancer Diagnostics
Melbourne-based biotech company Sienna Cancer Diagnostics has announced the appointment of Dr John Chiplin to its board of directors. [ + ]
Are aliens extinct?
Why does evidence of alien life continue to elude Earth's scientists? Is it because such life never existed at all, or because it has already gone extinct? [ + ]
Predicting cancer immunotherapy response
IRX Therapeutics and ImmunID have entered into a collaboration to predict patients' response to the IRX-2 immunotherapy candidate using the ImmunTraCkeR assay. [ + ]
Chief Scientist Ian Chubb bids farewell
Professor Ian Chubb has completed his appointment as Australia's seventh Chief Scientist after almost five years in the role. [ + ]
Imugene to develop mimotope-based immunotherapies
Imugene has announced the extension of its partnership with the Medical University of Vienna to discover and develop new mimotope-based immunotherapies against validated and new oncology targets. [ + ]
How reptile embryos cope with climate change
Western Australian researchers have discovered that the ability of sea turtles to respond to heat stress varies with their genes. [ + ]
